Samsara BioCapital »

Spyglass Pharma shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Spyglass Pharma shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2026-03-31 $55M 2.1M 25.91

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Mineralys Therapeutics (MLYS)
Alumis (ALMS)
Septerna (SEPN)
Kalaris Therapeutics (KLRS)
Spyglass Pharma Com Shs
Neurogene (NGNE)
Inventiva Sa Ads (IVA)
Sutro Biopharma Com Shs (STRO)
Jade Biosciences Com New (JBIO)
Vtv Therapeutics Cl A New (VTVT)
Aquestive Therapeutics (AQST)
X4 Pharmaceuticals Com New (XFOR)
Nkarta (NKTX)
Arcellx Common Stock (ACLX)

View all positions for Samsara BioCapital

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
Vestal Point Capital
Deerfield Management Company
Millennium Management
Vanguard Capital Management
First Light Asset Management
Franklin Resources
Standard Life Aberdeen
BlackRock
Geode Capital Management
Monashee Investment Management
Vanguard Fiduciary Trust

View all funds holding Spyglass Pharma